Back to company

Selma Diagnostics ApS: Financial statements 2018

CVR: 36961376

Selma Diagnostics ApS (CVR 36961376) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -1,662,659 and a net result of DKK -2,588,588 compared with DKK -2,251,061 the year before. Equity amounted to DKK 1,513,214. The solvency ratio was 79.5%. The company had 3 employees in the financial year.

Gross Profit
-1,662,659 kr.
Profit/Loss
-2,588,588 kr.
Equity
1,513,214 kr.
Total Assets
1,903,824 kr.
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018--1.7 mio.-2.6 mio.1.5 mio.3
2017--1.9 mio.-2.3 mio.4.1 mio.2

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Selma Diagnostics ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2018

Selma Diagnostics ApS: The 2017 annual report is outMar 15, 2018

Selma Diagnostics ApS has published its annual report for 2017. Gross profit came to DKK -1,928,065, and the net result was DKK -2,251,061.

About Selma Diagnostics ApS

Selma Diagnostics ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2015. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Andreas Hjarne Kunding. The company's owners include John Alexander, CARSTEN GOMARD HOLDING ApS and Selma Diagnostics ApS. The company has 3 employees. In 2025, the company reported a gross profit of DKK -1,093,508 and a net result of DKK -3,060,808 compared with DKK -2,178,400 the year before. Equity amounted to DKK -11,154,823.